Parhaat Rheumatology News International Podcastit (2024)

1
Episode 6: Recent Advances in RA 20:55

15y ago20:55

20:55

Recent Advances in RA, features a telephone interview with Professor Josef SmolenKirjoittanut rhnews@elsevier.com (Rheumatology News International)

1
Episode 5: Novel Endpoints in RA Diagnosis and Management Monitoring Anemia, Fatigue, and Cardiovascular Status 16:07

15y ago16:07

16:07

Novel Endpoints in RA Diagnosis and Management: Monitoring Anemia, Fatigue, and Cardiovascular Status, features a telephone interview with Professor Iain McInnes.Kirjoittanut rhnews@elsevier.com (Rheumatology News International)

1
Episode 4: Treatment Needs in Patients with Psoriatic Arthitis features a telephone interview with Professor Douglas Veale 14:43

15y ago14:43

14:43

Treatment Needs in Patients with Psoriatic Arthitis features a telephone interview with Professor Douglas VealeKirjoittanut rhnews@elsevier.com (Rheumatology News International)

1
Episode 3: How Would Early Treatment Affect Disease and Quality-of-Life Outcomes in Spondyloarthritis (SpA) 14:43

15+ y ago14:43

14:43

This podcast, How Would Early Treatment Affect Disease and Quality-of-Life Outcomes in Spondyloarthritis (SpA)?, features a telephone interview with Professor Joachim Sieper.Kirjoittanut rhnews@elsevier.com (Rheumatology News International)

1
Episode 2: Predicting the Onset and Disease Course of Rheumatoid Arthritis 14:43

15+ y ago14:43

14:43

This podcast, Predicting the Onset and Disease Course of Rheumatoid Arthritis, features a telephone interview with Professor Lars Klareskog.Kirjoittanut rhnews@elsevier.com (Rheumatology News International)

1
Episode 1: Patient Impressions of Biologic Treatment for Rheumatoid Arthritis 14:43

15+ y ago14:43

14:43

This first podcast in a new series titled Patient Impressions of Biologic Treatment for RA: Highlights from the RAISE Study features an interview with Professor Haraoui. He reviews a review a new study that allows rheumatologists to predict the value of using combined treatment in patients based on disease markers.…

1
Episode 6: Individualizing Therapy: Today’s Options, Tomorrow’s Opportunities 19:02

15+ y ago19:02

19:02

This sixth podcast program, Individualizing Therapy: Today’s Options, Tomorrow’s Opportunities, features an interview with Professor McInnes. He discusses the current state of knowledge in rheumatoid arthritis and directions for discovery in coming years.Kirjoittanut rhnews@elsevier.com (Rheumatology News International)

1
Episode 5: Progress and Prognosis: Evaluating Patients' Responses to Biologic Therapy 16:18

15+ y ago16:18

16:18

This fifth podcast titled Progress and Prognosis: Evaluating Patients’ Responses to Biologic Therapy features a telephone interview with Professor Schett. He discusses differences among the anti-TNF agents in the treatment of rheumatoid arthritis.Kirjoittanut rhnews@elsevier.com (Rheumatology News International)

1
Episode 4: Individualizing Treatment in Rheumatoid Arthritis: The Crucial Impact of Patient Heterogeneity 14:21

16y ago14:21

14:21

Professor VonVollenhoven discusses factors which distinguish individual responses by patients with rheumatoid arthritis to various anti-TNF agents. He describes observations of radiologic and clinical progression of illness in subgroups of patients and provides an overview of considerations in choosing one pharmacologic agent over another. Professo…

1
Episode 3: Anti-TNF Treatment: Focus on early Rheumatoid Arthritis. Featuring an interview with Professor Paul Emery 14:21

16y ago14:21

14:21

Contemporary research shows that the early diagnosis and treatment of RA can offer patients the possibility of achieving remission. The goal for any patient with early RA should be to achieve remission. If a patient does not already have joint damage, the goal should be a normal acute-phase response and no swollen joints as soon as possible.…

1
Episode 2: Establishing the Evidence: Clinical Trials with TNF Inhibitors 14:53

16y ago14:53

14:53

Professor Smolen discusses the evidence supporting the ability of TNF-alpha agents to result in substantial and sustained improvement in symptoms of psoriatic arthritis. Agents including infliximab and etanercept result in not only clinical improvement but also slow the radiographic progression of joint disease and damage. Further, the combination …

1
Episode 1: TNF-Alpha: Concept to Proof of Concept 14:53

16+ y ago14:53

14:53

Professor Sir Ravinder Maini's groundbreaking work on the characterization of TNF-alpha began in the mid-1980's with his collaboration with Professor Mark Feldman. In his study of intercellular messenger molecules, Professor Sir Maini utilized two new technologies -- protein sequencing and cDNA protein coding -- to investigate half a dozen cytokine…

Kuuntelemisen arvoisia podcasteja

Rheumatology News International podcastit

Kuuntelemisen arvoisia podcasteja

1
Biologic Therapy In Rheumatoid Arthritis

rhnews@elsevier.com (Rheumatology News International)

1
Biologic Therapy in Rheumatic Diseases

rhnews@elsevier.com (Rheumatology News International)

1
Episode 6: Recent Advances in RA 20:55

1
Episode 5: Novel Endpoints in RA Diagnosis and Management Monitoring Anemia, Fatigue, and Cardiovascular Status 16:07

1
Episode 4: Treatment Needs in Patients with Psoriatic Arthitis features a telephone interview with Professor Douglas Veale 14:43

1
Episode 3: How Would Early Treatment Affect Disease and Quality-of-Life Outcomes in Spondyloarthritis (SpA) 14:43

1
Episode 2: Predicting the Onset and Disease Course of Rheumatoid Arthritis 14:43

1
Episode 1: Patient Impressions of Biologic Treatment for Rheumatoid Arthritis 14:43

1
Episode 6: Individualizing Therapy: Today’s Options, Tomorrow’s Opportunities 19:02

1
Episode 5: Progress and Prognosis: Evaluating Patients' Responses to Biologic Therapy 16:18

1
Episode 4: Individualizing Treatment in Rheumatoid Arthritis: The Crucial Impact of Patient Heterogeneity 14:21

1
Episode 3: Anti-TNF Treatment: Focus on early Rheumatoid Arthritis. Featuring an interview with Professor Paul Emery 14:21

1
Episode 2: Establishing the Evidence: Clinical Trials with TNF Inhibitors 14:53

1
Episode 1: TNF-Alpha: Concept to Proof of Concept 14:53

Pikakäyttöopas